Jayson Bedford
Stock Analyst at Raymond James
(4.73)
# 725
Out of 5,119 analysts
737
Total ratings
60.4%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Reiterated: Buy | $155 → $165 | $150.87 | +9.37% | 15 | Nov 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $94 → $97 | $79.41 | +22.15% | 77 | Oct 30, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $483 → $480 | $452.80 | +6.01% | 17 | Oct 21, 2026 | |
| AXGN Axogen | Reiterated: Buy | $48 → $53 | $50.02 | +5.96% | 9 | Sep 25, 2026 | |
| MDT Medtronic | Reiterated: Hold | n/a | $101.80 | - | 30 | Sep 2, 2026 | |
| ICUI ICU Medical | Reiterated: Buy | $180 → $200 | $172.11 | +16.20% | 60 | Aug 7, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $83 → $100 | $87.23 | +14.64% | 46 | Jul 31, 2026 | |
| SYK Stryker | Reiterated: Buy | $418 → $370 | $325.87 | +13.54% | 5 | Jul 31, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | n/a | $109.93 | - | 85 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $209 → $265 | $276.22 | -4.06% | 69 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $263 → $216 | $146.51 | +47.43% | 46 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $88 | $42.75 | +105.85% | 76 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $105.59 | - | 9 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 | $102.14 | n/a | 30 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $26.59 | n/a | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $8.59 | n/a | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $25.79 | n/a | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.42 | n/a | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $211.88 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.15 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.91 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $11.73 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
Teleflex
Nov 6, 2026
Reiterated: Buy
Price Target: $155 → $165
Current: $150.87
Upside: +9.37%
DexCom
Oct 30, 2026
Reiterated: Buy
Price Target: $94 → $97
Current: $79.41
Upside: +22.15%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $483 → $480
Current: $452.80
Upside: +6.01%
Axogen
Sep 25, 2026
Reiterated: Buy
Price Target: $48 → $53
Current: $50.02
Upside: +5.96%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $101.80
Upside: -
ICU Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $180 → $200
Current: $172.11
Upside: +16.20%
Merit Medical Systems
Jul 31, 2026
Reiterated: Buy
Price Target: $83 → $100
Current: $87.23
Upside: +14.64%
Stryker
Jul 31, 2026
Reiterated: Buy
Price Target: $418 → $370
Current: $325.87
Upside: +13.54%
Abbott Laboratories
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $109.93
Upside: -
Johnson & Johnson
Jul 16, 2026
Reiterated: Buy
Price Target: $209 → $265
Current: $276.22
Upside: -4.06%
Jun 8, 2026
Reiterated: Buy
Price Target: $263 → $216
Current: $146.51
Upside: +47.43%
Mar 27, 2026
Reiterated: Buy
Price Target: $124 → $88
Current: $42.75
Upside: +105.85%
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $105.59
Upside: -
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $102.14
Upside: n/a
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $26.59
Upside: n/a
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $8.59
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $25.79
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $13.42
Upside: n/a
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $211.88
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $11.15
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: n/a
Current: $16.91
Upside: n/a
Apr 17, 2023
Reiterated: Buy
Price Target: $14 → $13
Current: $11.73
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a